188 related articles for article (PubMed ID: 8923365)
1. Increased pigmentation in scleroderma.
Pope JE; Shum DT; Gottschalk R; Stevens A; McManus R
J Rheumatol; 1996 Nov; 23(11):1912-6. PubMed ID: 8923365
[TBL] [Abstract][Full Text] [Related]
2. Localization of endothelin-1 and its binding sites in scleroderma skin.
Vancheeswaran R; Azam A; Black C; Dashwood MR
J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
[TBL] [Abstract][Full Text] [Related]
3. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
Sawaya HH; Jimenez SA; Artlett CM
Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
[TBL] [Abstract][Full Text] [Related]
4. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.
Manneschi LI; Del Rosso A; Milia AF; Tani A; Nosi D; Pignone A; Generini S; Giacomelli R; Cerinic MM
Rheumatology (Oxford); 2005 May; 44(5):607-13. PubMed ID: 15728417
[TBL] [Abstract][Full Text] [Related]
5. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
Furst DE; Clements PJ; Steen VD; Medsger TA; Masi AT; D'Angelo WA; Lachenbruch PA; Grau RG; Seibold JR
J Rheumatol; 1998 Jan; 25(1):84-8. PubMed ID: 9458208
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
[TBL] [Abstract][Full Text] [Related]
7. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
Santiago B; Galindo M; Rivero M; Pablos JL
Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
9. Variations of neuronal nitric oxide synthase in systemic sclerosis skin.
Ibba-Manneschi L; Niissalo S; Milia AF; Allanore Y; Del Rosso A; Pacini A; Manetti M; Toscano A; Cipriani P; Liakouli V; Giacomelli R; Kahan A; Konttinen YT; Matucci-Cerinic M
Arthritis Rheum; 2006 Jan; 54(1):202-13. PubMed ID: 16385516
[TBL] [Abstract][Full Text] [Related]
10. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
11. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
[TBL] [Abstract][Full Text] [Related]
12. HLA-G expression in the skin of patients with systemic sclerosis.
Wastowski IJ; Sampaio-Barros PD; Amstalden EM; Palomino GM; Marques-Neto JF; Crispim JC; Biral AC; Rassi DM; Carosella ED; Moreau P; Donadi EA
J Rheumatol; 2009 Jun; 36(6):1230-4. PubMed ID: 19369464
[TBL] [Abstract][Full Text] [Related]
13. Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma.
Flavahan NA; Flavahan S; Liu Q; Wu S; Tidmore W; Wiener CM; Spence RJ; Wigley FM
Arthritis Rheum; 2000 Aug; 43(8):1886-90. PubMed ID: 10943881
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
[TBL] [Abstract][Full Text] [Related]
15. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
Davies CA; Jeziorska M; Freemont AJ; Herrick AL
Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
[TBL] [Abstract][Full Text] [Related]
16. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma).
Sprott H; Müller-Ladner U; Distler O; Gay RE; Barnum SR; Landthaler M; Schölmerich J; Lang B; Gay S
J Rheumatol; 2000 Feb; 27(2):402-4. PubMed ID: 10685805
[TBL] [Abstract][Full Text] [Related]
17. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.
Bezante GP; Rollando D; Sessarego M; Panico N; Setti M; Filaci G; Molinari G; Balbi M; Cutolo M; Barsotti A; Indiveri F; Ghio M
J Rheumatol; 2007 Dec; 34(12):2431-7. PubMed ID: 17985401
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous side effects from laser treatment of the skin: skin cancer, scars, wounds, pigmentary changes, and purpura--use of pulsed dye laser, copper vapor laser, and argon laser.
Haedersdal M
Acta Derm Venereol Suppl (Stockh); 1999; 207():1-32. PubMed ID: 10605602
[TBL] [Abstract][Full Text] [Related]
19. The scleroderma neck sign.
Weinstein CL; Miller MH; Kossard S; Littlejohn GO
J Rheumatol; 1989 Dec; 16(12):1533-5. PubMed ID: 2625682
[TBL] [Abstract][Full Text] [Related]
20. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
Kissin EY; Merkel PA; Lafyatis R
Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
